GLP-1 agonist

This week, I began a three-month course of Ozempic, the wonder drug touted to reduce cardiovascular risk for the overweight and those with diabetes.

During my lifetime, there have been several seminal breakthroughs in medicine that greatly changed our ability to prevent or treat disease. Part 1, below, describes several of them. I have a good idea of what some of the next ones will be.